ArticleJSES international2026
Grade III and IV glenohumeral chondral defects do not portend worse patient-reported outcomes at 2 years after rotator cuff repair.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypothesis/Background: The purpose of this study is to investigate the differences in patient-reported outcomes (PROs) at 2 years after arthroscopic rotator cuff repair (RCR) in patients with grade III and IV chondral defects of the glenohumeral joint and in those without, and to report early revision to arthroplasty at 2 years. We hypothesized no difference in PROs and revision surgery at 2 years. Methods: A consecutive cohort of patients undergoing RCR were prospectively enrolled and retrospectively reviewed. Patients were classified as low-grade if they had grade 0, I, or II chondral defects and as high-grade if they had grade III or IV chondral defects determined by Outerbridge classification. PROs such as the American Shoulder and Elbow Surgeons (ASES) score, the Single Assessment Numeric Evaluation, the Simple Shoulder Test, the pain the Visual Analog Scale, and the Veterans RAND 12-Item Health Survey (VR-12) were collected. Early revisions to arthroplasty were recorded. Results: Of 1,057 patients eligible, 26 patients with high-grade defects were included. A 5:1 cohort matching was performed, resulting in a sample size of 156 patients. At two years postoperatively, ASES Function and ASES Index scores remained without significant difference, respectively ( Conclusion: The presence of grade III and IV chondral defects do not portend a worse clinical outcome by measure of the selected PROs at 2 years after RCR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.